New Heidelberg SPECTRALIS®
Due to the combined generous support of the Sarah Slack Fund at Muskingum Community Foundation, Jerry Colp, and Dr. Alan Letson, OSU can proudly announces the addition of a Heidelberg SPECTRALIS® to its imaging division. With its multi-functional imaging capabilities, the SPECTRALIS® is helping drive the development of novel treatments and changing the course of eye disease management.
The SPECTRALIS® provides high resolution ocular imaging of the retina, choroid, cornea, and anterior chamber. The imaging capabilities include standard retina photography along with wide angle images, video angiography with both Fluorescein and ICG dye, and state of the art fundus autofluorescence imaging. The SPECTRALIS® also provides high resolution spectral domain Ocular Coherence Tomography (OCT) imaging that permits identification of subcellular level structures within the retina. Additional software for imaging of the optic nerve, useful in diagnosing and managing glaucoma, has also been acquired.
"The SPECTRALIS® is not only an everyday ‘workhorse’ for managing our current patients with wet AMD [macular degeneration] and other retinal diseases," said Dr. Letson, a faculty member and long-time donor, "but, it provides the capabilities needed for participation in the current wave of AMD research and clinical trials. It’s exactly what the late Dr. Havener and my former patient, the late Sarah Slack, whose generosity has contributed significantly to our mission, would have wanted. It’s like the ‘Holy Grail’ to finding a way to either treat or prevent vision loss from macular degeneration, especially Dry AMD. Without the SPECTRALIS®, we would not be able to participate in any of the new clinical research evaluating promising treatments for Dry AMD. We are excited to get started."
We are grateful for the generosity of the Slack Fund at Muskingum Community Foundation, Mr. Colp, and Dr. Letson that allowed us to acquire this amazing piece of equipment which will expand options for rapid diagnoses and more detailed management of patients with eye disease.